Clients/Companies To Watch

Synthetic Biologics (NYSE Amex: SYN) is a biotechnology company focused on the development of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses. Synthetic Biologics is developing, or has partnered the development of, product candidates to treat pulmonary arterial … Continue reading →

Alexza Pharmaceuticals, Inc., a specialty pharmaceutical development stage company, focuses on the research, development, and commercialization of products for the acute treatment of central nervous system conditions. Its technology, Staccato system, vaporizes an excipient-free drug to form a condensation aerosol … Continue reading →

Access Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes propriety products for the treatment and supportive care of cancer patients. Its products include ProLindac, which is in Phase II clinical testing of patients with ovarian cancer; and MuGard for the … Continue reading →